Abstract:Objectives Clinical and experimental observations indicated that HMG-CoA reductase inhibitors (statins) have pleiotropic effects. The present study was designed to elucidate the status of cyclic adenosine monophosphate (c-GMP), Cyclooxygenase-2 (COX-2), Carbon Monoxide Haemoglobin (COHb) and haem oxygenase-1 (HO-1) to the antoxidative effects of Simvastatin in the hypercholesterolemic rabbit. Methods Twenty four male Japanese white (JW) rabbits weighing approximately 2.0 kg were used in this study. The animals were randomised into three groups of eight animals each: one control group and other two groups which were maintained on high-cholesterol diet (HCD) for 24 weeks. After 8 weeks on this diet, the animals were divided into two groups: non-treated group and simvastatin group; the animals were euthanised with an overdose of sodium pentobarbital at the end 24th week. The aorta were excised, placed in ice-cold sterile saline, and cleaned of connective tissue. Blood was taken through cardiac puncture and plasma was used for biochemical assay of lipid peroxides. Levels of HbCO, COX-2 and cGMP were measured by Enzyme-Linked Immunosorbent Assay (ELISA) kits. HO-1mRNA in arterial were analysed using Real Time Quantitative PCR methods, and expression of MMP-9 protein was measured by immunohisto-chemical assay, serum malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were also measured. Results Twenty-four weeks of atherogenic diet significantly increased the levels of MDA cytotoxic (19.72±2.60 vs 14.24±1.87 ng/ml control group), and SOD (1.31±0.45 vs 7.92±1. μg/ml control), cGMP (18.66±1.47 vs 12.54±1.45 nmol/l control group) decreased in serum; HO-1mRNA expression of non-treated group is no different than the control group (1.75±1.02 vs 1.34±0.63), but is showing the tendency to increase (3.22±1.67vs 1.75±1.02 non-treated group, p=0.062) after treatment with Simvastatin. SOD, NO and cGMP were as well as increased (p<0.01 or p<0.05), but MMP-9 and HbCO (56.12±11.67 vs 101.0±41.55 µg/ml non-treated group) decreased significantly than the non-treated group (p<0.01 or p<0.05) after treatment with Simvastatin. Simvastatin partially restored the HO-1, SOD and NO, decreased MDA and HbCO levels, but to COX-2(67.69±6.39 vs 68.90±9.04 U/l non-treated group), no differences among groups were observed. Conclusions Atherosclerosis induced an oxidative damage and simvastatin had significant anti-atherogenic and anti-oxidation effects in an animal model with rabbits fed a hypercholesterolemic diet, maybe it mediated by HO-1, restoring the SOD and NO levels and reducing cytotoxic MDA levels.

Simvastatin Reduces Connexin43 Expression and Inhibits Rabbit Atherosclerotic Lesion Formation

Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits.

Regulation of Connexin Expression after Balloon Injury: Possible Mechanisms for Antiproliferative Effect of Statins.

Effects of Losartan on Expression of Connexins at the Early Stage of Atherosclerosis in Rabbits.

Atorvastatin Prevents Connexin43 Remodeling in Hypertrophied Left Ventricular Myocardium of Spontaneously Hypertensive Rats.

Effects of Angiotensin II on Connexin 43 of VSMCs in Arteriosclerosis

Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.

Simvastatin Reduces Expression and Activity of Lipoprotein-Associated Phospholipase A(2) in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits.

Effects of losartan and ramipril on the connexin expression in a rabbit balloon injury model

Simvastatin Attenuates the Additive Effects of TNF-α and IL-18 on the Connexin 43 Up-Regulation and Over-Proliferation of Cultured Aortic Smooth Muscle Cells.

Effects of Simvastatin in A Rabbit Model of Atherosclerosis: Role of Ho-1/Co-Cgmp Pathway and Related Anti-Oxidative Enzyme Expression

Effect of simvastatin on expression of carnitine patmitoyl transferase-1 in vascular smooth muscle layer of atherosclerotic rabbits

The Connexin43 expression in the role of Ginkg biloba inhibiting Formation of atherosclerotic plaques in rabbit

Effect of simvastatin on expression of glucose transporter-4mRNA in vascular smooth muscle layer of atherosclerotic rabbits

Studies on the Simvastatin Effect on the Artery of Atherosclerotic Rabbit Using Proteomics Approaches

Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta’s Stiffness in Hypercholesterolemic Rabbits

Influence of Simvastatin on Immune Complexes in the Plaque Lesion of Atherosclerosis

The effects of simvastatin on angiogenesis: studied by an original model of atherosclerosis and acute myocardial infarction in rabbit

Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.

Effects of Atorvastatin on Expression of ICAM-1 in Atherosclerotic Rabbits.

Effect of Simvastatin on Expression of Tissue Inhibitor of Matrix Metalloproteinase-1 in Iliac Artery of Atherosclerotic Rabbits